SCHEMBL23837331

SCHEMBL23837331

CC(C)(C#N)CC(=O)N[C@H]1Cc2cccc(C(=O)N=O)c2OB1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17337072 0.89 KCNA3 (0.31) —
SCHEMBL17337069 0.89 KCNA3 (0.31) —
SCHEMBL23837470 0.79 PARP1 (0.33) —
SCHEMBL23837356 0.77 — —
SCHEMBL18957145 0.76 PARP1 (0.32) —
SCHEMBL18957148 0.76 PARP1 (0.32) —
SCHEMBL23837281 0.75 — —
SCHEMBL23837296 0.74 HTT (0.40) —
SCHEMBL17349994 0.74 TSHR (0.36) —
SCHEMBL17337205 0.74 DRD2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback